As a new decade begins, we’re on the cusp of a full-scale transformation in life sciences. As mentioned in Gartner’s recent report, Predicts 2020: Life Science CIOs Must Digitalize for Business Growth, “AI (artificial intelligence) is one of the most powerful, transformational technologies to enable new business models, customer experiences, service offerings, and business ecosystems across multiple industries.” That transformation is underway in the way life sciences companies manage their commercial operations.
This year’s European Veeva Commercial and Medical Summit welcomed more than 1,300 professionals from the life sciences industry in Barcelona. At the event, Gerhard Arnhofer, VP, Head of Integrated Multichannel Marketing at Bayer, and David Ehrlich, CEO of Aktana, presented how Bayer is partnering with Aktana to incorporate AI across commercial operations to create greater […]
It’s a topic that will only become more pressing as artificial intelligence (AI) solidifies its status as a “must-have” tool for sales teams across industries. From financial services to life sciences, companies are working to not only define new compensation structures, but also overcome operational hurdles and drive internal adoption. These trends mean reps may […]
The Veeva Commercial Summit in Sao Paulo is right around the corner, and we’re getting ready by sitting down with one of the newest members of our customer success team, Eduardo Alonso. With 21 years experience working at major pharmaceutical companies and consulting firms in Brazil, Eduardo has a wealth of insight about the current […]
We returned as a platinum sponsor once again to the Veeva Commercial and Medical Summit, which welcomed over 1,700 attendees in Philadelphia this year. At the event, Eva Martins, Global Head of Innovative Models and Commercial Transformation at Novartis, and Derek Choy, Co-founder and COO at Aktana, presented how Novartis is partnering with Aktana to […]
The demand for AI-driven personalization and cohesive experiences across channels is prompting a change in go-to-market execution. Healthcare providers (HCPs) are demanding a more connected experience. It’s important, now more than ever, for commercial teams to shift away from the traditional annual, cycle-driven execution model to more a more frequent, agile approach. This will help […]
We recently hosted our annual Aktana Innovators Forum in New York City. The event brought together life sciences leaders for a series of discussions about the role of artificial intelligence (AI) in the new commercial model. 2019 will be a transformative year for many life sciences companies and the forum offered opportunities to connect with […]
Meeting the expectations of healthcare providers (HCPs) should be obvious, but often this sentiment is easier said than done, especially in the life sciences industry. The complex landscape of this market in Japan makes this task even more challenging, filled with complicated regulations, contracts, and various stakeholders. How can we ensure our reps are providing […]
Machine learning is easily one of the most heavily discussed buzzwords within life sciences in the past few years. Defined as a process where large amounts of data and algorithms give a machine the ability to learn how to perform tasks and identify patterns, it often gets a bad rap. Although there are clear benefits […]
Across industries, innovators are finding ways to use data and analytics to be disruptive. This combination fuels the need for organizations to have advanced data capabilities in order to stay competitive. Many life sciences companies aim to meet this challenge by tapping the resources and expertise of their in-house data analytics teams. However, these teams […]
